Company / Working Capital
Perspective Therapeutics, Inc. Working Capital History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$50.1M
FY2022
5-year range
$3.6M / $65.5M
FY2018-FY2022
Trend
-23.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from $4M in FY2018 to $66M in FY2021.
Based on SEC 10-K filings.
$50M in FY2022 with a 5-year CAGR of +40.4%.
Improved from $4M to $50M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +100.7%
- 5-Year CAGR
- +40.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +40.4%, indicating consistent growth.
- In FY2022, working capital decreased 23.5% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $50.1M | -23.5% |
| FY2021 | $65.5M | +1565.8% |
| FY2020 | $3.9M | -36.5% |
| FY2019 | $6.2M | +71.5% |
| FY2018 | $3.6M | -60.7% |
| FY2017 | $9.2M | -26.7% |
| FY2016 | $12.5M | -17.7% |
| FY2015 | $15.2M | -15.7% |
| FY2014 | $18.1M | +394.7% |
| FY2013 | $3.7M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026